trials are reviewed and approved by independent ethics committees , ensuring that the rights , safety , and well-being of trial participants are protected .
Veeda conducts regular internal audits and welcomes inspections by regulatory authorities to maintain high standards of quality and ethics . We also ensure that all participants provide informed consent before enrolling in a trial . We invest in continuous training and education for its staff to keep them updated on the latest ethical guidelines , regulatory requirements , and best practices in clinical research .
Veeda Clinical Research has grown significantly over the years . What key factors have driven this growth , and how do you see the company evolving in the next five years ?
Over the years , we have maintained strong connections with leading Veeda ’ s global pharmaceutical and biotech clients can now leverage the unique and unparalleled suite of early to late-phase CRO services across Europe , US , and Asia Pacific . However , our involvement with innovator companies was limited due to a lack of late-phase clinical trial and initial drug
“ In 2020 , India accounted for 8.3 % of global clinical trial activity , a notable increase from the tenyear average of 6.2 %.
development experience . In the last three years , Veeda ’ expansion into the preclinical business has positioned us to start engaging more meaningfully in innovative drug development .
Veeda ’ s ever-growing relationship with large biopharma companies and access to Key Opinion Leaders across multiple countries will accelerate execution of global clinical trials in both the western and eastern populations . In recent years , Veeda has added expertise in the late stage clinical and global trials for large molecules . High quality and efficient clinical trial execution remains the top priority for Veeda .
A unique blend of scientists and researchers , having deep therapeutic area expertise in the Oncology research , will enable us to drive greater efficiency , innovation , and excellence in delivering research outcomes for drug development programs of our clients worldwide . By combining expertise in the late-phase clinical trials with our expanded expertise and infrastructure in pre-clinical and phase I studies , Veeda is aiming to create a more comprehensive and integrated platform that delivers exceptional value to its clients and partners across the globe .
BIOVOICENEWS . COM 29